OPKO HEALTH, INC.'s Net Worth

$113 Million

Estimate Recalculated Oct 6, 2025 08:24PM EST

Who is OPKO HEALTH, INC.

OPKO HEALTH, INC. has an estimated net worth of $113 Million. This is based on reported shares across multiple companies, which include VBI Vaccines Inc/BC, Sevion Therapeutics, Inc., BIOZONE PHARMACEUTICALS, INC., RXi Pharmaceuticals Corp, Sorrento Therapeutics, Inc., and GeneDx Holdings Corp..

SEC CIK

OPKO HEALTH, INC.'s CIK is 0000944809

Past Insider Trading and Trends

2017 was OPKO HEALTH, INC.'s most active year for acquiring shares with 5 total transactions. OPKO HEALTH, INC.'s most active month to acquire stocks was the month of July. 2013 was OPKO HEALTH, INC.'s most active year for disposing of shares, totalling 20 transactions. OPKO HEALTH, INC.'s most active month to dispose stocks was the month of July. 2023 saw OPKO HEALTH, INC. paying a total of $4,999,999.90 for 37,433,862 shares, this is the most they've acquired in one year. In 2024 OPKO HEALTH, INC. cashed out on 911,631 shares for a total of $29,696,019.92, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VBI Vaccines Inc/BC

Investor
Updated Nov 09, 2017
Form 3
Nov 09, 2017
6.02M
Form 4
10.89%
655.74K
$3.05
$2.00M
Nov 01, 2017
6.68M
Purchase
Oct 30
Showing 2 results

Sevion Therapeutics, Inc.

Investor
Updated Dec 21, 2017
Form 4
62.30%
495.13K
Dec 21, 2017
1.29M
Grant
Dec 19
Form 4
8.04%
1.18M
Nov 07, 2017
15.89M
Options
Sep 19
Form 4
0.87%
126.82K
$0.10
$412.68K
Aug 14, 2017
14.64M
Options
Aug 10
Form 3
Aug 04, 2017
10.52M
Showing 4 results

BIOZONE PHARMACEUTICALS, INC.

Investor
Updated Mar 17, 2014
Form 3
Mar 17, 2014
18.70M
Showing 1 results

RXi Pharmaceuticals Corp

Investor
Updated Mar 13, 2013
Form 3
Mar 13, 2013
67.24M
Showing 1 results

Sorrento Therapeutics, Inc.

Investor
Updated Nov 27, 2013
Form 4
-0.96%
-20.81K
$8.54
-$177.76K
Nov 27, 2013
2.15M
Sale
Nov 25 - Nov 26
Form 4
-0.39%
-8.47K
$8.50
-$72.00K
Nov 25, 2013
2.17M
Sale
Nov 22
Form 4
-0.20%
-4.27K
$8.53
-$36.40K
Nov 22, 2013
2.18M
Sale
Nov 21
Form 4
-0.77%
-17.06K
$8.75
-$149.29K
Nov 21, 2013
2.19M
Sale
Nov 19 - Nov 20
Form 4
-0.12%
-2.71K
$8.75
-$23.71K
Nov 18, 2013
2.20M
Sale
Nov 15
Form 4
-0.09%
-1.90K
$8.75
-$16.62K
Nov 15, 2013
2.21M
Sale
Nov 14
Form 4
-0.61%
-13.46K
$8.75
-$117.75K
Nov 14, 2013
2.21M
Sale
Nov 13
Form 4
-0.09%
-2.00K
$8.75
-$17.50K
Nov 12, 2013
4.44M
Sale
Nov 08
Form 4
-5.14%
-120.38K
$9.03
-$1.09M
Nov 08, 2013
2.22M
Sale
Nov 06 - Nov 07
Form 4
-0.40%
-9.36K
$7.75
-$72.52K
Sep 04, 2013
2.34M
Sale
Sep 04
Form 4
0.00%
-100.00
$7.75
-$775.00
Aug 30, 2013
2.35M
Sale
Aug 29
Form 4
-0.10%
-2.26K
$7.93
-$17.89K
Aug 28, 2013
2.35M
Sale
Aug 26 - Aug 28
Form 4
-0.07%
-1.56K
$7.78
-$12.13K
Aug 21, 2013
2.36M
Sale
Aug 20
Form 4
-0.12%
-2.90K
$8.95
-$25.95K
Aug 16, 2013
2.36M
Sale
Aug 14
Form 4
-0.01%
-331.00
$8.50
-$2.81K
Aug 15, 2013
2.36M
Sale
Aug 07
Form 3
Sep 22, 2009
59.02M
Showing 16 results

GeneDx Holdings Corp.

Investor
Updated Aug 19, 2024
Form 4
-5.02%
-139.82K
$34.02
-$4.76M
Aug 19, 2024
2.65M
Sale
Aug 15 - Aug 19
Form 4
-2.95%
-84.77K
$34.19
-$2.90M
Aug 14, 2024
2.79M
Sale
Aug 12 - Aug 13
Form 4
-3.79%
-112.99K
$31.54
-$3.56M
Aug 08, 2024
2.87M
Sale
Aug 06 - Aug 08
Form 4
-2.89%
-88.84K
$33.50
-$2.98M
Aug 02, 2024
2.98M
Sale
Jul 31
Form 4
-1.60%
-50.00K
$33.86
-$1.69M
Jul 31, 2024
3.07M
Sale
Jul 29
Form 4
-4.14%
-135.00K
$33.78
-$4.56M
Jul 26, 2024
3.12M
Sale
Jul 24 - Jul 26
Form 4
-4.40%
-150.00K
$32.98
-$4.95M
Jul 23, 2024
3.26M
Sale
Jul 19 - Jul 23
Form 4
-0.73%
-25.00K
$32.93
-$823.19K
Jul 19, 2024
3.41M
Sale
Jul 17
Form 4
-1.04%
-36.12K
$28.24
-$1.02M
Jul 09, 2024
3.43M
Sale
Jul 05
Form 4
-2.50%
-89.08K
$27.58
-$2.46M
Jul 03, 2024
3.47M
Sale
Jul 01 - Jul 03
Form 4
24.55%
23.15M
Apr 13, 2023
117.43M
Grant
Apr 11
Form 4
17.86%
14.29M
$0.35
$5.00M
Jan 31, 2023
94.29M
Purchase
Jan 26
Form 3
May 09, 2022
80.00M
Showing 13 results